Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Lymphocytes from 278 gynaecological patients (100 controls and 178 patients with a malignant condition) have been investigated for their response to encephalitogenic factor, cancer basic protein, and KCl extract of adenocarcinoma of the body of the uterus as "antigens", using tanned sheep erythrocytes ETS as indicator particles in the electrophoretic mobility test (EMT). Electrophoretic mobility was measured with a Zeiss cytopherometer. The study was split into three test series producing in the cancer group 66% correct positive test results (34% false negatives) and in the control group 83% correct negative results (17% false positives). Consequently, with the instrumentation used, EMT is, at least in our hands, not sufficiently reliable for the diagnosis of cancer.
D000230:Adenocarcinoma / Q000276:immunology; D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000276:immunology; D004586:Electrophoresis; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis*; D006801:Humans; D008214:Lymphocytes / Q000276:immunology*; D008875:Middle Aged; D004676:Myelin Basic Protein / Q000276:immunology; D009363:Neoplasm Proteins / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
D000951:Antigens, Neoplasm; D004676:Myelin Basic Protein; D009363:Neoplasm Proteins